Clinical Trial Update: Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pharmacokinetics and safety of tiotropium inhalation powder from bromide salt in Hard Capsule via HandiHaler 2 vs Spiriva HandiHaler in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• HandiHaler 2 (tiotropium)
• SPIRIVA HANDIHALER (TIOTROPIUM BROMIDE)
• tiotropium inhalation powder (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED